Bayer, based in Germany, conducted tests and introduced the compound acetylsalicylic acid to the field of medicine in the late 1890s. Pioneers in its development include Heinrich Dreser, Arthur Eichengrün, and Felix Hoffmann. Aspirin, the resulting drug, was officially marketed in 1899 under a registered trademark. The account of this discovery first emerged in 1934 as a footnote in a history of chemical engineering authored by Albrecht Schmidt, a chemist associated with IG Farbenindustrie—into which F Bayer & Co had been incorporated in 1925.
Acetylsalicylic acid demonstrates both anti-inflammatory and antipyretic effects. Moreover, it acts as an inhibitor of platelet aggregation and is employed in the prevention of blood clots, strokes, and myocardial infarctions.
Since its debut by Bayer in 1899, aspirin has evolved into one of the most extensively used and renowned medications globally. By 1915, Bayer Pharmaceuticals developed the inaugural tablet form, which was subsequently distributed worldwide as a medicinal product.
Discovery history of Casprin
